IP Library Granted Patent US 8,293,876
Granted Patent B2
US 8,293,876 · App. 12/033,316 · Granted Oct 23, 2012

Method of purification of hydrophobic proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,293,876
App. No.
12/033,316
Granted
Oct 23, 2012
Kind
B2
Abstract

The present invention relates to a method for obtaining highly purified hydrophobic proteins from cells by extraction using a buffer containing a detergent and removal of said detergent by hydroxyapatite (HA) column chromatography.

Claims (64)

1. A method for purifying recombinant synthetic Lyme antigen (rSLA) comprising the steps of:

(i) subjecting a homogenate of cells containing the rSLA to microdiafiltration comprising the steps of:

(a) concentrating said homogenate by microfiltration;

(b) washing the biomass by microdiafiltration, thereby obtaining a microdiafiltrate-1 and a microdiaretentate-1;

(c) extracting the rSLA from said microdiaretentate-1 by microdiafiltration using a buffer containing a detergent thereby obtaining a microdiafiltrate-2 and a microdiaretentate-2;

(ii) subjecting said microdiafiltrate-2 containing the extracted rSLA to ion exchange chromatography, the eluent thereof containing the purified rSLA;

(iii) subjecting the eluent obtained from the ion exchange chromatography in step (ii) to anion exchange filtration for residual endotoxin removal; and

(iv) subjecting the such obtained protein solution containing the rSLA to hydroxyapatite (HA) column chromatography.

2. The method according to claim 1 , wherein, prior to step (i), the cell homogenate is washed using a suitable buffer selected from the group consisting of: Tris-buffer, HEPES buffer, citrate buffer, and phosphate buffer.

3. The method according to claim 1 , wherein, prior to step (iv), the filtrate obtained from said extraction step (ii) is subjected to ion exchange chromatography.

4. The method according to claim 1 , wherein, prior to step (iv), the filtrate obtained from said extraction step (ii) is subjected to anion exchange filtration using a membrane adsorber.

5. The method according to claim 1 , wherein the cells containing said rSLA are host cells selected from the group consisting of E. coli , yeasts, plant cells, insect cells, avian cells or mammalian cells.

6. The method according to claim 1 , wherein the buffer used in step (i)(c) contains a detergent selected from the group consisting of anionic detergents, cationic detergents, zwitterionic detergents and non-ionic detergents,

wherein the anionic detergents are selected from the group consisting of cholic acids and derivatives thereof, N,N-dimethyldodecylamine N-oxide, sodium 1-alkylsulfonates, N lauroylsarcosine or fatty acid salts;

wherein the cationic detergents are selected from the group consisting of alkyl trimethyl ammonium bromide and derivatives thereof or benzalkonium chloride;

wherein the zwitterionic detergents are selected from the group consisting of dodecyl betaine, alkyl dimethylamine oxide and derivatives thereof or 3-(N,N-dimethylalkyl-ammonio)-propanesulfonates; and

wherein the non-ionic detergents are selected from the group consisting of octylphenol ethoxylates, polyoxyethylene sorbitan monooleates, alkyl poly(ethylene oxides) and derivatives thereof, alkyl polyglucosides or fatty alcohols.

7. The method of claim 6 , wherein the detergent is present in an amount from about 0.5% to about 3.0%.

8. The method of claim 6 , wherein the detergent is present in an amount from about 1% to about 1.5%.

9. The method according to claim 1 , wherein the buffer used in step (i)(c) is Tris-buffer.

10. The method according to claim 1 , wherein the buffer used in step (i)(c) contains octylphenol ethoxylate as a detergent.

11. The method according to claim 1 , wherein, after step (i)(c), a microfiltration and/or microdiafiltration step is performed using a 0.2 μm pore size microfiltration cassette.

12. The method according to claim 1 , wherein the buffer concentrations are in a range from about 0.1 mM to about 1.0M.

13. The method of claim 1 , wherein the buffer concentrations are in a range from about 1.0 mM to about 600 mM.

14. The method of claim 1 , wherein the pH of the buffers ranges from about 3.0 to about 10.0.

15. The method of claim 1 , wherein the pH of the buffers ranges from about 6.0 to about 8.0.

16. The method of claim 1 , wherein the method is carried out at room temperature.

17. The method of claim 1 , wherein the method is carried out at a temperature from about 0° C. to about 15° C.

18. A method for purifying recombinant synthetic Lyme antigen (rSLA) from a cell comprising the steps of:

(i) providing cells containing said rSLA;

(ii) homogenizing said cells;

(iii) subjecting the such obtained homogenate to microdiafiltration comprising the steps of:

(a) concentrating said homogenate by microfiltration;

(b) washing the biomass by microdiafiltration, thereby obtaining a microdiafiltrate-1 and a microdiaretentate-1;

(c) extracting rSLA from said microdiaretentate-1 by microdiafiltration using a buffer containing at least octylphenol ethoxylate, thereby obtaining a microdiafiltrate-2 and a microdiaretentate-2;

(iv) subjecting said microdiafiltrate-2 containing the extracted rSLA to anion exchange chromatography, the eluent thereof containing the purified rSLA;

(v) subjecting the eluent obtained from the anion exchange chromatography in step (iv) to anion exchange filtration for residual endotoxin removal; and

(vi) subjecting the such obtained protein solution containing rSLA to hydroxyapatite (HA) column chromatography.

19. The method according to claim 18 , wherein, prior to step (iii)(c), the cell homogenate is washed using a suitable buffer selected from the group consisting of: Tris-buffer, HEPES buffer, citrate buffer, and phosphate buffer.

20. The method according to claim 18 , wherein, prior to hydroxyapatite column chromatography step (vi), the filtrate obtained from step (iii)(c) is subjected to ion exchange chromatography.

21. The method according to claim 18 , wherein, prior to hydroxyapatite column chromatography step (vi), the filtrate obtained from step (iii)(c) is subjected to anion exchange filtration using a membrane adsorber.

22. The method according to claim 18 , wherein the cells containing said hydrophobic protein are host cells selected from the group consisting of E. coli , yeasts, plant cells, insect cells, avian cells or mammalian cells.

23. The method according to claim 18 , wherein the buffer used in step (iii)(c) contains a detergent selected from the group consisting of anionic detergents, cationic detergents, zwitterionic detergents and non-ionic detergents,

wherein the anionic detergents are selected from the group consisting of cholic acids and derivatives thereof, N,N-dimethyldodecylamine N-oxide, sodium 1-alkylsulfonates, N lauroylsarcosine or fatty acid salts;

wherein the cationic detergents are selected from the group consisting of alkyl trimethyl ammonium bromide and derivatives thereof or benzalkonium chloride;

wherein the zwitterionic detergents are selected from the group consisting of dodecyl betaine, alkyl dimethylamine oxide and derivatives thereof or 3-(N,N-dimethylalkyl-ammonio)-propanesulfonates; and

wherein the non-ionic detergents are selected from the group consisting of octylphenol ethoxylates, polyoxyethylene sorbitan monooleates, alkyl poly(ethylene oxides) and derivatives thereof, alkyl polyglucosides or fatty alcohols.

24. The method of claim 23 , wherein the detergent is present in an amount from about 0.5% to about 3.0%.

25. The method of claim 23 , wherein the detergent is present in an amount from about 1% to about 1.5%.

26. The method according to claim 17 , wherein the buffer used in step (iii)(c) is Tris-buffer.

27. The method according to claim 18 , wherein the buffer used in step (iii)(c) contains octylphenol ethoxylate as a detergent.

28. The method according to claim 18 , wherein, after step (iii)(c), a microfiltration and/or microdiafiltration step is performed using a 0.2 μm pore size microfiltration cassette.

29. The method according to claim 18 , wherein the buffer concentrations are in a range from about 0.1 mM to about 1.0M.

30. The method of claim 18 , wherein the buffer concentrations are in a range from about 1.0 mM to about 600 mM.

31. The method of claim 18 , wherein the pH of the buffers ranges from about 3.0 to about 10.0.

32. The method of claim 18 , wherein the pH of the buffers ranges from about 6.0 to about 8.0.

33. The method of claim 18 , wherein the method is carried out at room temperature.

34. The method of claim 18 , wherein the method is carried out at a temperature from about 0° C. to about 15° C.

35. The method of claim 1 , further comprising a step of ultrafiltration between step (iii) and step (iv).

36. The method of claim 1 , further comprising a final step of sterile filtration.

37. The method of claim 36 , further comprising a step of ultrafiltration between step (iv) and the final step of sterile filtration.

38. The method of claim 18 , further comprising a step of ultrafiltration between step (v) and step (vi).

39. The method of claim 18 , further comprising a final step of sterile filtration.

40. The method of claim 39 , further comprising a step of ultrafiltration between step (vi) and the final step of sterile filtration.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA PREVIOUSLY RECORDED AT REEL: 036359 FRAME: 0631. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 24, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036433/0699 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE S.A.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036359/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036373/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2008
From: TAUER, CHRISTA; MITTERER, ARTUR
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 021015/0486 →